Other indications (e.g. myeloproliferative diseases)
Follow-Up Treatment
Assess the Safety and Efficacy of Bomedemstat (IMG-7289) versus Best Available Therapy (BAT) in Patients with
Essential Thrombocythemia who are Resistant to or Intolerant of Hydroxyurea
Assess the Safety and Efficacy of Bomedemstat (IMG-7289) versus Best Available Therapy (BAT) in Patients with
Essential Thrombocythemia who are Resistant to or Intolerant of Hydroxyurea
